What is the ESPR stock price prediction for next 2 weeks?

According to our price prediction algorithm,Esperion Therapeutics, Inc. (ESPR) price will be around $1.90 in the next 2 weeks. This means it will decrease by -7.507317073170729 from the last closing price. This prediction may vary from other time period filters for ESPR stock.

What can be the highest Possible price of ESPR stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, ESPR can achieve the highest price of $2.07 which is 0.992537392768091 higher than last closing price. This prediction may vary from other time period filters for ESPR stock.

What can be the lowest Possible price of ESPR stock in next 2 weeks?

As per the forecast and algorithmic analysis, ESPR stock price can be as low as $1.73 which is -15.806378973842083 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for ESPR stock.

Will ESPR stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that ESPR stock will lose-7.507317073170729 in the next 2 weeks. This prediction may vary from other time period filters for ESPR stock.

What is ESPR stock last closing price?

Last closing price of ESPR stock was $2.05.

What is ESPR stock price prediction?

ESPR stock price prediction means predicting the future closing prices of ESPR stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of ESPR stock in a certain time period.

How we predict ESPR stock future prices?

If you are searching for ESPR stock forecast, analysis or price prediction, then you might be wondering what Esperion Therapeutics, Inc. (ESPR) will do in the future. Our ESPR price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This ESPR price prediction will likely answer most of your questions.

How frequent we update ESPR stock predictions?

We are updating the forecasts for the ESPR stock on daily basis.

Is using ML forecasting for ESPR stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for ESPR stock same for all the time periods?

No, the prediction for ESPR stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Esperion Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$2.05-21.46%Since 2 Weeks

Predicted Price$1.90-7.51%For 2 Weeks

Upper Predicted Price$2.070.99%For 2 Weeks

Lower Predicted Price$1.73-15.81%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of ESPR will decline by -7.51% over the next 2 Weeks and hit $1.90 by Tuesday, April 28, 2026. In that time frame, ESPR's share price is expected to range between $1.73 and $2.07.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Apr 28, 2026	1.73	1.90	2.07
Apr 27, 2026	1.84	2.01	2.17
Apr 24, 2026	1.72	1.90	2.08
Apr 23, 2026	1.77	1.93	2.11
Apr 22, 2026	1.80	1.98	2.16
Apr 21, 2026	1.83	1.99	2.16
Apr 20, 2026	1.93	2.10	2.29
Apr 17, 2026	1.82	1.99	2.15
Apr 16, 2026	1.85	2.02	2.19
Apr 15, 2026	1.90	2.07	2.26

ESPR shares fell -4.33% in Thursday, April 16, 2026's trading session, dropping from a previous close of $2.17 to move at $2.08. The stock demonstrated notable intraday movement (see ESPR's key stats for a full breakdown), fluctuating between $2.06 and $2.21, a +7.28% trading range. While recent weeks have seen some volatility, ESPR has managed to secure a -24.23% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 7.8M shares changing hands, 1.96M more than the previous session. This amounted to $16.18M in total market activity.

Will ESPR Continue Its Downward Trend?

According to analyst ratings and projections for ESPR, Esperion Therapeutics, Inc. shares are anticipated to decrease by -0.27%, potentially reaching $2.07 per share by April 28, 2026. Short-term technical indicators currently suggest a neutral sentiment for ESPR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 10 positive trading days within the past 30 sessions. Based on the ESPR stock forecast, now is not the best time to buy ESPR stock because its current trading price is +9.49% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ESPR covering social and institutional perspectives.

ESPR Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into ESPR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 31.27% to 35.37%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 42.20%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.70%, maintains a neutral outlook for the long term. Insights into ESPR's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Esperion Therapeutics Short-Term Forecasts

ESPR Forecast For Next 5 Days

Our algorithm anticipates Esperion Therapeutics (ESPR) stock could hit $1.82 by Apr 23, 2026. This represents a -12.14% fall from today's price, following a -18.59% change over the past five days.

ESPR Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Esperion Therapeutics, Inc. (ESPR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.69, which would mean a -18.59% decrease from the current price of $2.08. Projections for this period range from a high of $2.19 to a low of $1.10.

ESPR Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Esperion Therapeutics's price over the next three months point to a rise. ESPR stock is expected to peak at $15.97 on Jun 22, 2026 after potentially dipping to $6.70 on May 28, 2026. On average, ESPR is likely to trade around $10.56 in the coming 90 days.

Esperion Therapeutics Stock Forecast 2025

Based on our predictive models, Esperion Therapeutics (ESPR) is expected to trade between $6.70 and $37.98 throughout 2026. This would result in an average price of $19.14, potentially offering investors a +821.97% return from current levels.

Esperion Therapeutics, Inc. Monthly Forecast 2026–2027

April 2026

According to our latest forecast models, Esperion Therapeutics, Inc. (ESPR) is positioned to show a strong performance in April 2026. The price is predicted to move between $7.68 and $8.62, settling at an average of $8.15. This could translate to a +292.58% gain.

May 2026

Based on current market signals, Esperion Therapeutics, Inc. is projected to trend may 2026. We forecast a trading range from $6.70 to $8.42, with a likely average price of $7.50. Investors could expect a potential return of +261.27%.

June 2026

Our predictive algorithms indicate Esperion Therapeutics, Inc. stock may see a shift in June 2026. The expected range spans $7.64–$15.97, with an average target of $13.13. This represents a positive outlook and a possible gain of +532.47%.

July 2026

Analyzing established trends, Esperion Therapeutics, Inc. looks set to move in July 2026. Projections place the stock between $12.53 and $18.37, averaging around $14.79. This suggests a +612.43% gain from current levels.

August 2026

Market indicators suggest Esperion Therapeutics, Inc. could experience notable changes during August 2026. Prices could fluctuate within $14.74 to $23.15, with a midpoint forecast of $17.24. The stock might deliver a +730.44% gain.

September 2026

Forecasting for September 2026, models estimate that Esperion Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $21.18 and $26.92, averaging $23.66. This signals a positive trajectory with potential returns around +1,039.69%.

October 2026

According to our latest forecast models, Esperion Therapeutics, Inc. (ESPR) is positioned to show a strong performance in October 2026. The price is predicted to move between $19.91 and $26.19, settling at an average of $22.33. This could translate to a +975.63% gain.

November 2026

Based on current market signals, Esperion Therapeutics, Inc. is projected to trend november 2026. We forecast a trading range from $21.36 to $35.79, with a likely average price of $28.25. Investors could expect a potential return of +1,260.79%.

December 2026

Our predictive algorithms indicate Esperion Therapeutics, Inc. stock may see a shift in December 2026. The expected range spans $26.93–$37.98, with an average target of $31.17. This represents a positive outlook and a possible gain of +1,401.45%.

January 2027

Analyzing established trends, Esperion Therapeutics, Inc. looks set to move in January 2027. Projections place the stock between $23.61 and $34.35, averaging around $26.15. This suggests a +1,159.63% gain from current levels.

February 2027

Market indicators suggest Esperion Therapeutics, Inc. could experience notable changes during February 2027. Prices could fluctuate within $23.29 to $35.63, with a midpoint forecast of $26.57. The stock might deliver a +1,179.87% gain.

March 2027

Forecasting for March 2027, models estimate that Esperion Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $12.99 and $28.85, averaging $17.12. This signals a positive trajectory with potential returns around +724.66%.

April 2027

According to our latest forecast models, Esperion Therapeutics, Inc. (ESPR) is positioned to show a strong performance in April 2027. The price is predicted to move between $14.76 and $24.84, settling at an average of $18.35. This could translate to a +783.91% gain.

ESPR's history of dividends and stock splits also plays a role in long-term investor confidence.